Calcitonin vs Lanreotide
Overview
Calcitonin is primarily a bone & joint peptide, while Lanreotide is used for hormonal.
This page compares Calcitonin and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Calcitonin | Lanreotide | |
|---|---|---|
| Category | Bone & Joint | Hormonal |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 100-200 IU | 60-120 mg |
| Frequency | daily | every 4 weeks |
| Reported benefits | Reduced bone loss, pain relief in bone diseases | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Nasal irritation (spray form), nausea | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. Calcitonin is categorised under Bone & Joint, while Lanreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Calcitonin: FDA-approved. Lanreotide: FDA-approved.
Dosing. Calcitonin is typically dosed at 100-200 IU (daily). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking Calcitonin and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Calcitonin and Lanreotide?
- Calcitonin is primarily a bone & joint peptide, while Lanreotide is used for hormonal. Calcitonin is FDA-approved for one or more indications, whereas Lanreotide is FDA-approved for one or more indications.
- What is Calcitonin used for?
- FDA-approved bone resorption inhibitor.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take Calcitonin and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking Calcitonin and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Calcitonin or Lanreotide FDA-approved?
- Calcitonin is FDA-approved for one or more indications. Lanreotide is FDA-approved for one or more indications.
Read the full articles
- Calcitonin — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references